The Mysterious Dark Genome
Dark genome, accounting for ~985% of the human genome and including the non-coding part, uses extraordinary chance to try to find unique aspects that might contribute in human health. This non-coding area includes repeat aspects, enhancers, regulative series and non-coding RNAs. This session will explore this interesting brand-new frontier in biology and how to equate this so called “scrap” and formerly disregarded genome into prospective unique therapies.
Angela Shen, MD, Vice President, Strategic Innovation Leaders, Mass General Brigham Innovation
Richard Young, PhD, Professor, Whitehead Institute, MIT
Rosana Kapeller, MD, PhD, Co-Founder, President & CEO, ROME Therapeutics
Josh Mandel-Brehm, President & CEO, CAMP4 Therapeutics
Amir Nashat, PhD, Managing Partner, Polaris Ventures
Issi Rozen, Venture Partner, GV
No comments:
Post a Comment